These findings suggest a potential mechanism in which ALDH3A2 downregulates SLC47A1, thereby restricting NRF2 nuclear translocation, impairing UPRmt function, and promoting ferroptosis, which may ultimately contribute to the malignant progression of GC. The gene discussed is ALDH3A2; the disease is gastric cancer.